Crestwood Advisors Group LLC Chroma Dex Corp. Transaction History
Crestwood Advisors Group LLC
- $5.07 Billion
- Q3 2024
A detailed history of Crestwood Advisors Group LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 11,891 shares of CDXC stock, worth $42,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,891
Previous 12,045
1.28%
Holding current value
$42,569
Previous $32,000
34.38%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CDXC
# of Institutions
87Shares Held
16.5MCall Options Held
91.7KPut Options Held
18.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$12.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$11.2 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$10.6 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$4.64 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$4.05 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $245M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...